Page 81 - Read Online

stress-induced neuronal microdamage that can grade into a 36. Maizels RM, Yazdanbakhsh M. Immune regulation by helminth
chronic neuroinflammatory condition? Neurosci Biobehavioral Rev parasites: cellular and molecular mechanisms. Nat Rev Immunol
2011;35:742-64. 2003;3:733-44.
18. Watanabe T, Nobusawa S, Kleihues P, Ohgaki H. IDH1 mutations 37. Humphries W, Wei J, Sampson JH, Heimberger AB. The role of
are early events in the development of astrocytomas and tregs in glioma-mediated immunosuppression: potential target for
oligodendrogliomas. Am J Pathol 2009;174:1149-53. intervention. Neurosurg Clin N Am 2010;21:125-37.
19. Dang L, White DW, Gross S, Bennett BD, Bittinger MA, 38. Sonabend AM, Rolle CE, Lesniak MS. The role of regulatory T cells
Driggers EM, Fantin VR, Jang HG, Jin S, Keenan C, Marks KM, in malignant glioma. Anticancer Res 2008;28:1143-50.
Prins RM, Ward PS, Yen KE, Liau LM, Rabinowitz JD, Cantley LC, 39. El Andaloussi A, L esniak MS. An increase in
Thompson CB, Vander Heiden MG, Su SM. Cancer-associated CD4+CD25+FOXP3+regulatory T cells in tumor-infiltrating
IDH1 mutations produce 2-hydroxyglutarate. Nature 2010;465:966. lymphocytes of human glioblastoma multiforme. Neuro Oncol
20. Piaskowski S, Bienkowski M, Stoczynska-Fidelus E, Stawski R, 2006;8:234-43.
Sieruta M, Szybka M, Papierz W, Wolanczyk M, Jaskolski DJ, 40. Fecci PE, Mitchell DA, Whitesides JF, Xie W, Friedman AH,
Liberski PP, Rieske P. Glioma cells showing IDH1 mutation cannot Archer GE, Herndon JE, Bigner DD, Dranoff G, Sampson JH.
be propagated in standard cell culture conditions. Br J Cancer Increased regulatory T-cell fraction amidst a diminished CD4
2011;104:968-70. compartment explains cellular immune defects in patients with
21. Kölker S, Pawlak V, Ahlemeyer B, Okun JG, Hörster F, Mayatepek E, malignant glioma. Cancer Res 2006;66:3294-302.
Krieglstein J, Hoffmann GF, Köhr G. NMDA receptor activation 41. El Andaloussi A, Sonabend AM, Han Y, Lesniak MS. Stimulation
and respiratory chain complex V inhibition contribute to of TLR9 with CpG ODN enhances apoptosis of glioma and
neurodegeneration in d-2-hydroxyglutaric aciduria. Eur J Neurosci prolongs the survival of mice with experimental brain tumors. Glia
2002;16:21-8. 2006;54:526-35.
22. Guemez-Gamboa A, Estrada-Sanchez AM, Montiel T, Páramo B, 42. Peng G, Guo Z, Kiniwa Y, Voo KS, Peng W, Fu T, Wang DY, Li Y,
Massieu L, Morán J. Activation of NOX2 by the stimulation of Wang HY, Wang RF. Toll-like receptor 8-mediated reversal of
ionotropic and metabotropic glutamate receptors contributes to CD4+regulatory T cell function. Science 2005;309:1380-4.
glutamate neurotoxicity in vivo through the production of reactive 43. Schwartzbaum J, Ahlbom A, Malmer B, Lonn S, Brookes AJ,
oxygen species and calpain activation. J Neuropathol Exp Neurol Doss H, Debinski W, Henriksson R, Feychting M. Polymorphisms
2011;70:1020-35. associated with asthma are inversely related to glioblastoma
23. Fogal B, Hewett SJ. Interleukin-1beta: a bridge between multiforme. Cancer Res 2005;65:6459-65.
inflammation and excitotoxicity? J Neurochem 2008;106:1-23. 44. Wiemels JL, Wiencke JK, Patoka J, Moghadassi M, Chew T,
24. Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines and McMillan A, Miike R, Barger G, Wrensch M. Reduced
disease. Ann Rev Cell Biol 1993;9:317-43. immunoglobulin E and allergy among adults with glioma compared
25. Woiciechowsky C, Schoning B, Stoltenburg-Didinger G, with controls. Cancer Res 2004;64:8468-73.
Stockhammer F, Volk HD. Brain-IL-1 beta triggers astrogliosis 45. Leidi M, Gotti E, Bologna L, Miranda E, Rimoldi M, Sica A,
through induction of IL-6: inhibition by propranolol and IL-10. Med Roncalli M, Palumbo GA, Introna M, Golay J. M2 macrophages
Sci Monit 2004;10:BR325-30. phagocytose rituximab-opsonized leukemic targets more efficiently
26. Soehnlein O, Lindbom L. Phagocyte partnership during the onset than m1 cells in vitro. J Immunol 2009;182:4415-22.
and resolution of inflammation. Nat Rev Immunol 2010;10:427-39. 46. te Velde AA, de Waal Malefijt R, Huijbens RJ, de Vries JE, Figdor CG.
27. Allen JE, Wynn TA. Evolution of Th2 immunity: a rapid IL-10 stimulates monocyte Fc gamma R surface expression and
repair response to tissue destructive pathogens. PLoS Pathog cytotoxic activity. Distinct regulation of antibody-dependent
2011;7:e1002003. cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. J Immunol
28. D’Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, 1992;149:4048-52.
Aste M, Chan SH, Kobayashi M, Young D, Nickbarg E. Production 47. Huettner C, Czub S, Kerkau S, Roggendorf W, Tonn JC. Interleukin
of natural killer cell stimulatory factor (interleukin 12) by peripheral 10 is expressed in human gliomas in vivo and increases glioma cell
blood mononuclear cells. J Exp Med 1992;176:1387-98. proliferation and motility in vitro. Anticancer Res 1997;17:3217-24.
29. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. 48. Huettner C, Paulus W, Roggendorf W. Messenger RNA expression
Immunosuppressive effects of apoptotic cells. Nature 1997;390:350-1. of the immunosuppressive cytokine IL-10 in human gliomas. Am J
30. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. Pathol 1995;146:317-22.
The chemokine system in diverse forms of macrophage activation 49. Lisi L, Stigliano E, Lauriola L, Navarra P, Dello Russo C.
and polarization. Trends Immunol 2004;25:677-86. Proinflammatory-activated glioma cells induce a switch in microglial
31. Duluc D, Delneste Y, Tan F, Moles MP, Grimaud L, Lenoir J, polarization and activation status, from a predominant M2b
Preisser L, Anegon I, Catala L, Ifrah N, Descamps P, Gamelin E, phenotype to a mixture of M1 and M2a/B polarized cells. ASN
Gascan H, Hebbar M, Jeannin P. Tumor-associated leukemia Neuro 2014;6:e00144.
inhibitory factor and IL-6 skew monocyte differentiation into 50. Samaras V, Piperi C, Korkolopoulou P, Zisakis A, Levidou G,
tumor-associated macrophage-like cells. Blood 2007;110:4319-30. Themistocleous MS, Boviatsis EI, Sakas DE, Lea RW, Kalofoutis A,
32. Voehringer D, Shinkai K, Locksley RM. Type 2 immunity reflects Patsouris E. Application of the ELISPOT method for comparative
orchestrated recruitment of cells committed to IL-4 production. analysis of interleukin (IL)-6 and IL-10 secretion in peripheral
Immunity 2004;20:267-77. blood of patients with astroglial tumors. Mol Cell Biochem
33. Anthony RM, Rutitzky LI, Urban JF Jr, Stadecker MJ, Gause WC. 2007;304:343-51.
Protective immune mechanisms in helminth infection. Nat Rev 51. Wagner S, Czub S, Greif M, Vince GH, Suss N, Kerkau S,
Immunol 2007;7:975-87. Rieckmann P, Roggendorf W, Roosen K, Tonn JC. Microglial/
34. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. macrophage expression of interleukin 10 in human glioblastomas.
Interleukin 10(IL-10) inhibits cytokine synthesis by human Int J Cancer 1999;82:12-6.
monocytes: an autoregulatory role of IL-10 produced by monocytes. 52. Liu H, Jacobs BS, Liu J, Prayson RA, Estes ML, Barnett GH,
J Exp Med 1991;174:1209-20. Barna BP. Interleukin-13 sensitivity and receptor phenotypes of
35. D’Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, human glial cell lines: non-neoplastic glia and low-grade astrocytoma
Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte differ from malignant glioma. Cancer Immunol Immunother
interferon gamma-production by suppressing natural killer cell 2000;49:319-24.
stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 53. Badie B, Schartner JM. Flow cytometric characterization
1993;178:1041-8. of tumor-associated macrophages in experimental gliomas.

74 Neuroimmunol Neuroinflammation | Volume 1 | Issue 2 | September 2014